Economic Evaluation of Health Behavior Interventions to Prevent and Manage Type 2 Diabetes Mellitus in Asia: A Systematic Review of Randomized Controlled Trials

Padam Kanta Dahal (), Lal B. Rawal, Rashidul Alam Mahumud, Grish Paudel, Tomohiko Sugishita and Corneel Vandelanotte
Additional contact information
Padam Kanta Dahal: School of Health, Medical and Applied Sciences, Central Queensland University, Sydney, NSW 2000, Australia
Lal B. Rawal: School of Health, Medical and Applied Sciences, Central Queensland University, Sydney, NSW 2000, Australia
Rashidul Alam Mahumud: NHRMC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2006, Australia
Grish Paudel: School of Health, Medical and Applied Sciences, Central Queensland University, Sydney, NSW 2000, Australia
Tomohiko Sugishita: Section of Global Health, Division of Public Health, Department of Public Health, Tokyo Women’s Medical University, Tokyo 162-8666, Japan
Corneel Vandelanotte: Appleton Institute, Physical Activity Research Group, Central Queensland University, Rockhampton, QLD 4702, Australia

IJERPH, 2022, vol. 19, issue 17, 1-20

Abstract: Health behavior interventions implemented in Asian countries often lack economic evaluations that effectively address the problems of type 2 diabetes mellitus. This review systematically assessed the existing literature on economic evaluation of health behavior interventions to prevent and manage type 2 diabetes mellitus for people living in Asian countries. Eligible studies were identified through a search of six bibliographic databases, namely, PubMed, Scopus, Public Health Database by ProQuest, Cumulative Index to Nursing and Allied Health Literature Complete, Web of Science, and Google Scholar. Randomized controlled trials of health behavior interventions and studies published in the English language from January 2000 to May 2022 were included in the review. The search yielded 3867 records, of which 11 studies were included in the review. All included studies concluded that health behavior interventions were cost-effective. Eight of these studies undertook an evaluation from a health system perspective, two studies used both societal and health system perspectives, and one study utilized a societal and multi-payer perspective. This review identified the time horizon, direct and indirect medical costs, and discount rates as the most important considerations in determining cost effectiveness. These findings have implications in extending health behavior interventions to prevent and manage type 2 diabetes mellitus in low-resource settings, and are likely to yield the most promising outcomes for people with type 2 diabetes mellitus.

Keywords: health behavior interventions; type 2 diabetes mellitus; Asian countries; economic evaluation; discount rate; cost effectiveness (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/17/10799/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/17/10799/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:17:p:10799-:d:902124

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().